|
09:00 - 10:10
|
Thème 2 : Interactions cellules/scaffold et cellules/environnement (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) |
(+)
|
|
09:00 - 09:30 |
› Optimization of stem cell properties by Heparan sulfate mimetics : towards new therapeutic strategies for the treatment of osteoarthritis. - Patricia ALBANESE, Gly-CRRET Laboratory, Glycobiology, Growth, Repair, and Tissue Regeneration (GlyCRRET), EA 4397, |
|
|
09:30 - 10:00 |
› CHEMICAL, PHYSICAL AND BIOLOGICAL STRATEGIES TO MODIFY CELLULOSE/ SOY PROTEIN COMPOSITES-BASED NERVE CONDUITS FOR PERIPHERAL NERVE REGENERATION - Y. Chen, School of Basic Medical Sciences, Wuhan University |
|
|
10:00 - 10:10
|
Explore Agilent cell analysis technologies to gain deeper insight into stem cell function and uncover mechanisms involved in cellular reprogramming and differentiation (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) - C. IOCHEM - Agilent Technologies |
|
|
10:10 - 11:15
|
Pause café & Posters (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) |
|
|
11:15 - 12:15
|
Thème 2 : Interactions cellules/scaffold et cellules/environnement (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) |
(+)
|
|
11:15 - 11:30 |
› HYPOXIA PRECONDITIONING IMPROVES QUALITY OF MESENCHYMAL STEM CELLS AND ENPOWERS THEIR IMMUNOREGULATORY POTENTIAL - Yinping Li, School of Basic Medical Sciences, Wuhan University |
|
|
11:30 - 11:45 |
› DEVELOPMENT OF A MECHANICAL BIOPROCESS TO STIMULATE STEM CELLS FOR REGENERATIVE MEDECINE - Emilie Wiedemann-Fodé, Laboratoire d'Etude des Microstructures et de Mécanique des Matériaux |
|
|
11:45 - 12:00 |
› CHARACTERIZATION OF SMALL SIZE EXTRACELLULAR VESICLES FROM WHARTON'S JELLY MESENCHYMAL STEM CELLS DURING IN VITRO EXPANSION AND STUDY OF CXCR4 EXPRESSION - Stéphane BREZILLON, 1Université de Reims Champagne-Ardenne, UMR CNRS, 7369 MEDyC, Reims, France |
|
|
12:00 - 12:15 |
› NEUROTOXIC A1 ASTROCYTES PROMOTE NEURONAL FERROPTOSIS IN EPILEPSY - Song Han, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei Provincial Key Laboratory of Developmentally Originated Disease, Taikang Medical School, School of Basic Medical Sciences, Wuhan University, Wuhan, China |
|
|
12:15 - 14:00
|
Déjeuner (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) |
|
|
14:00 - 15:10
|
Thème 3 : Ingénierie cellulaire (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) |
(+)
|
|
14:00 - 14:30 |
› Bringing Mesenchymal stromal cells into the clinic - Nadir Kadri, Department of Laboratory Medicine |
|
|
14:30 - 15:00 |
› Use of MAIT cells as a new platform for universal CAR-expressing cells. - Sophie Caillat-Zucman, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Laboratoire d'Immunologie |
|
|
15:00 - 15:10
|
Umbilical Cord Stem Cells for Cell Therapy & Regenerative Medicine (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) - P. SQUIBAN - Health & Biotech France |
|
|
15:10 - 16:15
|
Pause café & Posters (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) |
|
|
16:15 - 17:15
|
Thème 3 : Ingénierie cellulaire (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) |
(+)
|
|
16:15 - 16:30 |
› DELIVERING LINE1 ANTISENSE OLIGONUCLEOTIDES VIA ENDOTHELIAL TARGETING EXTRACELLULAR VESICLES TO AMELIORATE MYOCARDIAL INFARCTION-INDUCED CARDIAC SENESCENCE - Zongjin Li, School of Medicine, Nankai University, Henan Key Laboratory of Cardiac Remodeling and Transplantation, Zhengzhou Seventh People's Hospital, Zhengzhou 450016, China |
|
|
16:30 - 16:45 |
› CAR-VST as a promising candidate to produce allogeneic CAR-T cells - Valentine Wang, IMoPA |
|
|
16:45 - 17:00 |
› Effect of the oxygenation on the growth of human wharton's jelly-mesenchymal stromal cells and extracellular vesicles production in mixed bioreactors - Kevin Audoux, Laboratoire Réactions et Génie des Procédés |
|
|
17:00 - 17:15 |
› EXAMPLE OF IMPROVEMENT OF THE ANTITUMOR POTENTIAL OF NATURAL KILLER CELLS WITHOUT GENE MODIFICATION: ARMING NK CELLS AGAINST MEDULLOBLASTOMA WITH ANTI-HER ANTIBODIES. - Mélanie GAUTHIER, Ingénierie Moléculaire, Cellulaire et Physiopathologie, Unité de Thérapie Cellulaire : CHRU Nancy - Veronique Decot, Ingénierie Moléculaire, Cellulaire et Physiopathologie, Unité de Thérapie Cellulaire : CHRU Nancy |
|
|
17:15 - 18:00
|
Sessions de clôture / Prix (Amphithéâtre LEPOIS – Faculté de Médecine, Maïeutique et Métiers de la Santé) - Pr C. Huselstein, University of Lorraine, CNRS, UMR 7365 |
|
